These findings align with studies linking low NLR and SII to better outcomes in ICI-treated R/M-HNSCC and non-small cell lung cancer (NSCLC) (22, 23), although some reports on albumin’s predictive role have been inconsistent (24). This evidence concerns the gene ALB and non-small cell lung carcinoma.